14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
DSGX vs CWAN: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Clearwater Analytics Holdings, Inc. (CWAN) is the stronger overall head-to-head candidate over Descartes Systems Group Inc (DSGX) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Options & Positioning, R&D & Supply-Chain Moat). DSGX carries a Unified Composite Score of 40.1/100 (SELL) at $89.20 (34.2x Forward P/E, 32.0% operating margin), whereas CWAN carries 63.2/100 (BUY) at $24.56 (94.5x Forward P/E, 4.1% operating margin).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DSGX vs CWAN. Trailing 12-month operating profitability (DSGX 32.0% vs CWAN 4.1%) and valuation multiples (DSGX 34.2x vs CWAN 94.5x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Software - Application value chain with $7.3B market capitalization and 4.1% operating margin.
OpEx & R&D Reinvestment61.9% of Rev ($511M)
90D Engineering Disclosures0 Published
Investor FAQ DSGX vs CWAN Key Questions & Quantitative Answers
As of Nov 20, 2026, Clearwater Analytics Holdings, Inc. (CWAN) is the stronger overall head-to-head candidate over Descartes Systems Group Inc (DSGX) in the Tradestie Institutional Equity Comparison Engine, winning 5–5 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Options & Positioning, R&D & Supply-Chain Moat). DSGX carries a Unified Composite Score of 40.1/100 (SELL) at $89.20 (34.2x Forward P/E, 32.0% operating margin), whereas CWAN carries 63.2/100 (BUY) at $24.56 (94.5x Forward P/E, 4.1% operating margin). Technically, DSGX sits in a Neutral phase (RSI 44.0, CONSOLIDATION options structure) and CWAN sits in a Markup phase (RSI 67.9, UNCLASSIFIED options structure).
CWAN leads the Growth & Scale pillar: DSGX posts +11.8% YoY revenue growth and +32.6% YoY earnings growth on $775M TTM revenue (77.6% gross margin, 32.0% operating margin), compared with CWAN at +74.4% YoY revenue growth and +202.8% YoY earnings growth on $826M TTM revenue (66.0% gross margin, 4.1% operating margin). On trailing 12-month operating scale, DSGX generates $775M in USD-normalized revenue versus $826M for CWAN. In operating R&D and SG&A reinvestment, DSGX deploys 45.6% of Rev ($353M) (0 90-day corporate R&D disclosures) versus 61.9% of Rev ($511M) (0 disclosures) for CWAN.
DSGX screens cheaper on headline valuation multiples. DSGX trades at 34.2x Forward P/E, 41.8x Trailing P/E, 1.53x PEG, and 9.4x EV/Revenue (38.5% FCF margin), whereas CWAN trades at 94.5x Forward P/E, 35.6x Trailing P/E, 1.78x PEG, and 8.9x EV/Revenue (13.2% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against DSGX (11.9% ROE) versus CWAN (-3.1% ROE) capital efficiency.
In options market volatility and institutional positioning, DSGX carries 42.6% implied volatility (13th %ile, Compressed (<25th %ile)), a 0.20x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.27β · 23% Vol realized risk). By comparison, CWAN carries 0.8% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.42β · 4% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.